dc.contributor.author | Butcher, Anna | |
dc.contributor.author | Gregg, Alison | |
dc.contributor.author | J. Scammells, Peter | |
dc.contributor.author | Rose'Meyer, Roselyn | |
dc.date.accessioned | 2017-05-03T12:46:26Z | |
dc.date.available | 2017-05-03T12:46:26Z | |
dc.date.issued | 2007 | |
dc.date.modified | 2008-05-22T07:08:22Z | |
dc.identifier.issn | 02724391 | |
dc.identifier.uri | http://hdl.handle.net/10072/18984 | |
dc.description.peerreviewed | Yes | |
dc.description.publicationstatus | Yes | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | John Wiley & Sons Inc. | |
dc.publisher.place | United States | |
dc.relation.ispartofstudentpublication | N | |
dc.relation.ispartofpagefrom | 529 | |
dc.relation.ispartofpageto | 537 | |
dc.relation.ispartofissue | 8 | |
dc.relation.ispartofjournal | Drug Development Research | |
dc.relation.ispartofvolume | 68 | |
dc.rights.retention | Y | |
dc.subject.fieldofresearch | Pharmacology and pharmaceutical sciences | |
dc.subject.fieldofresearchcode | 3214 | |
dc.title | Effect of a novel partial adenosine A(1) receptor agonist VCP102 in reducing ischernic damage in the mouse heart | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dc.type.code | C - Journal Articles | |
gro.faculty | Griffith Health, School of Medical Science | |
gro.date.issued | 2007 | |
gro.hasfulltext | No Full Text | |
gro.griffith.author | Rose'Meyer, Roselyn B. | |